000 | 01986 a2200553 4500 | ||
---|---|---|---|
005 | 20250518002641.0 | ||
264 | 0 | _c20200922 | |
008 | 202009s 0 0 eng d | ||
022 | _a1552-4981 | ||
024 | 7 |
_a10.1002/jbm.b.34251 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKlinder, Annett | |
245 | 0 | 0 |
_aAntibiotics release from cement spacers used for two-stage treatment of implant-associated infections after total joint arthroplasty. _h[electronic resource] |
260 |
_bJournal of biomedical materials research. Part B, Applied biomaterials _c07 2019 |
||
300 |
_a1587-1597 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xchemistry |
650 | 0 | 4 |
_aArthroplasty, Replacement, Hip _xmethods |
650 | 0 | 4 |
_aArthroplasty, Replacement, Knee _xmethods |
650 | 0 | 4 |
_aBone Cements _xchemistry |
650 | 0 | 4 |
_aDrug Carriers _xchemistry |
650 | 0 | 4 | _aDrug Liberation |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGentamicins _xchemistry |
650 | 0 | 4 |
_aHip Joint _xdrug effects |
650 | 0 | 4 | _aHip Prosthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKnee Joint _xsurgery |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPolymethyl Methacrylate _xchemistry |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aProsthesis-Related Infections _xdrug therapy |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVancomycin _xchemistry |
700 | 1 | _aZaatreh, Sarah | |
700 | 1 | _aEllenrieder, Martin | |
700 | 1 | _aRedanz, Sylvio | |
700 | 1 | _aPodbielski, Andreas | |
700 | 1 | _aReichel, Tobias | |
700 | 1 | _aBösebeck, Hans | |
700 | 1 | _aMittelmeier, Wolfram | |
700 | 1 | _aBader, Rainer | |
773 | 0 |
_tJournal of biomedical materials research. Part B, Applied biomaterials _gvol. 107 _gno. 5 _gp. 1587-1597 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jbm.b.34251 _zAvailable from publisher's website |
999 |
_c28930586 _d28930586 |